The Medicine Maker | The Medicine Maker

Video: Leading the Alpha Charge – with Øystein Soug

October 28, 2026

From the Norwegian Air Force to alpha-emitting radiopharmaceuticals, Øystein Soug has taken the unconventional route to biotech leadership

1 min read

Cell & Gene

Engineering a New Generation of Cancer-Fighting Cells

USC researchers develop a scalable cell engineering platform that could overcome key manufacturing and therapeutic limitations of CAR-based immunotherapies

Cell & Gene

Prime Editing Creates Drug-Controllable T Cell Therapies

Engineered T cells resisted tacrolimus but remained sensitive to cyclosporin, providing a potential way to select or suppress them after administration

Biopharma

Amgen Expands Veeva Partnership

Global deployment of Veeva Vault CRM aims to help Amgen uncover treatment barriers and accelerate the delivery of new therapies

Cell & Gene

Is Stem Cell Therapy Quality Control Missing Proteotoxic Cargo?

Review calls for senescence screening and EV proteomic profiling to assess whether cell therapy products can maintain protein homeostasis after transplantation

Cell & Gene Small Molecules Biopharma Future of Pharma

The voices driving change and progress in medicine making. Explore stories, interviews, and community highlights that inspire and inform.

Our celebration of the most inspirational and influential leaders in medicine.

Find out more

Ann Cleves

VP of Application Science, BioPharmics Division, Optibrium

View Profile

Bruce Levine

Barbara and Edward Netter Professor in Cancer Gene Therapy, University of Pennsylvania Perelman School of Medicine

View Profile

Musings from The Power List: Claudia Zylberberg

Claudia Zylberberg discusses building the infrastructure, partnerships, and policies needed to bring advanced therapies to patients at scale

Read the article

All the latest Medicine Maker articles.

Cell & Gene Business & Trends Power List

Surviving the Squeeze

October 26, 2026

The 2026 Power List discuss strategies for navigating today’s funding landscape in cell and gene therapy

4 min read

Cell & Gene Research News

Engineering CAR T Cells Inside Solid Tumors

October 26, 2026

Researchers develop targeted lipoplex platform that generates CAR T and NK cells directly within tumors, improving survival in preclinical breast cancer models

2 min read

Cell & Gene Development & Clinical Technology & Manufacturing

Live Roundtable: What Is the Biggest Bottleneck Holding Back Cell and Gene Therapy?

October 23, 2026

Industry leaders debate the manufacturing, regulatory, financial, and commercial barriers preventing advanced therapies from reaching more patients

1 min read

Industry News Development & Clinical Regulation & Standards Biopharma Future of Pharma Interviews

Can Clinical Trials Collect Less Data Without Compromising Safety?

October 22, 2026

Rob DiCicco discusses how FDA–industry collaboration is helping sponsors rethink safety reporting, selective safety data collection, and pragmatic clinical trial design.

5 min read

Outsourcing Sponsored

Choosing a Sterile Fill-Finish Partner

October 22, 2026

Alcami’s Kerrie Powell, Senior VP of Sales, discusses the challenges of sterile biologics manufacturing and what sponsors should look for in a CDMO partner

5 min read

Drug Delivery Sponsored

Meeting the Demands of Injectable Drug Delivery

October 22, 2026

Stevanato Group’s Adam Stops discusses how delivery systems and manufacturing capabilities can keep pace with increasingly complex drug formulations

1 min read

Research News Cell & Gene

CAR NK Cells Target Cancer and Autoimmunity

October 21, 2026

mRNA nanoparticles reprogram NK cells in vivo, inducing tumor remissions and reducing autoimmune liver damage in mice.

2 min read

Cell & Gene Research News

Prime Editing Corrects GATA2 Deficiency in Patient Stem Cells

October 21, 2026

The double-strand break-free approach increased functional GATA2 alleles and improved the engraftment of edited blood stem cells in mice

2 min read

Bioprocessing Biopharma Interviews

Analytical Champions: Robert Wethman

October 21, 2026

Bristol Myers Squibb’s Robert Wethman discusses real-time spectroscopy, AI, and the next era of biopharmaceutical manufacturing

6 min read

Drug Discovery Development & Clinical Interviews

How Genomics Is Personalizing Drug Discovery

October 20, 2026

Regeneron Genetics Center’s Luca Lotta explains how population-scale genetic evidence can reveal more promising drug targets and open new possibilities for disease prevention

4 min read

Top Stories